Ocuphire Pharma, Inc.
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily prese…
Biotechnology
US, Farmington Hills [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Ocuphire Pharma, Inc. has no acquisition track records yet.
M&A Deals · History
Ocuphire Pharma, Inc. has no acquisition track records yet.